Fate of intra-amniotically administered oestriol-15-3H-3-sulphate and oestriol-16-14C-16-glucosiduronate in pregnant women at midterm.
D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis*; D004064:Digestive System / Q000032:analysis*; D004964:Estriol / Q000378:metabolism*; D004967:Estrogens / Q000652:urine*; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006027:Glycosides / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000032:analysis*; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000032:analysis*; D011247:Pregnancy; D013431:Sulfates / Q000378:metabolism*
D004967:Estrogens; D006027:Glycosides; D013431:Sulfates; D004964:Estriol